The latest announcement is out from Riken Vitamin Co., Ltd. ( (JP:4526) ).
Riken Vitamin Co., Ltd. has announced an extraordinary income from the sale of investment securities to reduce cross-shareholdings, resulting in a gain of ¥1,613 million. This income will be recorded in the fourth quarter ending March 31, 2025, and has already been factored into the company’s full-year earnings forecast. The company will provide updates if any revisions to the forecast are necessary.
More about Riken Vitamin Co., Ltd.
Riken Vitamin Co., Ltd. operates in the food industry, focusing on the production and distribution of vitamins and related food additives. The company is known for its emphasis on health-oriented products and services, catering to a variety of market segments in the nutrition and wellness sectors.
YTD Price Performance: -4.00%
Average Trading Volume: 38,750
Technical Sentiment Consensus Rating: Hold
Current Market Cap: Yen60.02B
For detailed information about 4526 stock, go to TipRanks’ Stock Analysis page.